Effects of fetal exposure to maternal chemotherapy.
Jana Dekrem, Kristel Van Calsteren, Frédéric Amant
https://pubmed.ncbi.nlm.nih.gov/23856754/Actively Recruiting
Led by University Hospital, Gasthuisberg · Updated on 2024-03-06
5000
Participants Needed
33
Research Sites
400 weeks
Total Duration
Researchers are investigating the outcomes for mothers diagnosed with cancer during pregnancy, focusing on overall survival and the long-term development of children exposed to cancer or cancer treatments before birth. The study aims to understand how prenatal exposure to therapies like chemotherapy, radiation, or targeted treatments may affect childrens neurological and heart health as they grow. The study includes several parts initially, it registers and tracks maternal and neonatal health during pregnancy and delivery, including collecting blood samples and tissue biopsies. Emotional needs of parents facing a cancer diagnosis are assessed through questionnaires. The second part follows children exposed in utero to cancer treatments with regular check-ups at various ages up to adulthood, including neurological and cardiological exams, and optional MRI sessions. Participants will undergo scheduled assessments including blood sample collection, placental biopsies, and questionnaires for parents. Children will have neurological and heart evaluations at set ages from 6 months through 18 years, with further cardiologic monitoring every five years into adulthood. The research team monitors overall survival in mothers and developmental outcomes in children, ensuring comprehensive long-term follow-up extending potentially into the fourth decade of life for offspring.
CONDITIONS
Effects of Oncological Treatment During Pregnancy on Mother and Child
A
Ayaka Wakatsuki
K
Kristel Van Calsteren, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Gasthuisberg
Lead Sponsor
The Netherlands Cancer Institute
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Pregnancy until delivery
Maternal and fetal health are assessed during pregnancy and at delivery, including collection of maternal blood, umbilical cord blood, and placental biopsies.
Visits during pregnancy and delivery
Duration - From birth up to 43 years
Children exposed to chemotherapy or radiotherapy in utero undergo regular neurological and cardiological examinations and questionnaires to assess long-term health outcomes.
Check-ups at 6 months, 18 months, 3, 6, 9, 12, 15, and 18 years; cardiologic assessments and questionnaires every 5 years after 18 years; optional MRI sessions at 9, 12, 15, and 18 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jana Dekrem, Kristel Van Calsteren, Frédéric Amant
https://pubmed.ncbi.nlm.nih.gov/23856754/Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos...
https://pubmed.ncbi.nlm.nih.gov/23792410/Kristel Van Calsteren, Kristin Van Mensel, Steven Joniau...
https://pubmed.ncbi.nlm.nih.gov/16750250/Frédéric Amant, Lieselot Brepoels, Michael J Halaska...
https://pubmed.ncbi.nlm.nih.gov/19740709/Kristel Van Calsteren, Liesbeth Heyns, Frank De Smet...
https://pubmed.ncbi.nlm.nih.gov/19841323/Frédéric Amant, Gunter von Minckwitz, Sileny N Han...
https://pubmed.ncbi.nlm.nih.gov/23610117/Sileny N Han, Anouk Lotgerink, Mina Mhallem Gziri...
https://pubmed.ncbi.nlm.nih.gov/22873292/Frédéric Amant, Michael J Halaska, Monica Fumagalli...
https://pubmed.ncbi.nlm.nih.gov/24445819/Kristel Van Calsteren, Myriam Hanssens, Philippe Moerman...
https://pubmed.ncbi.nlm.nih.gov/18231896/Robert Fruscio, Jorine de Haan, Kristel Van Calsteren...
https://pubmed.ncbi.nlm.nih.gov/28029502/University Hospital, Gasthuisberg
Lead Sponsor
The Netherlands Cancer Institute
Collaborating Sponsor